Alzheimer's disease virus research spotlighted at HHV-6 conference
Alzheimer's disease virus research spotlighted at HHV-6 conference, reports Dr. Leslie Norins of Alzheimer's Germ Quest, Inc.
NAPLES, Fla., July 8, 2019 /PRNewswire/ -- Evidence indicating human herpesvirus 6 (HHV-6) and related herpesviruses may contribute to the causation of Alzheimer's disease was presented in late June in a day-long session of the 11th international HHV-6 conference, in Quebec City, reports Leslie Norins, MD, PhD, CEO of Alzheimer's Germ Quest, Inc. (AGQ) who attended.
"It was another sign that microbiological agents, including HHV-6, are finally beginning to receive the increased scrutiny in Alzheimer's disease research they've deserved for many years," says Dr. Norins.
He adds, "The entire spectrum of HHV-6 and its relatives' involvement in other 'mystery illnesses' is also intriguing." He credits the HHV-6 Foundation, and its co-founder/executive director, Kristin Loomis, with helping to maintain interest in this group of herpesviruses.
"It was another sign that microbiological agents, including HHV-6, are finally beginning to receive the increased scrutiny in Alzheimer's disease research they've deserved for many years," says Dr. Norins.
He adds, "The entire spectrum of HHV-6 and its relatives' involvement in other 'mystery illnesses' is also intriguing." He credits the HHV-6 Foundation, and its co-founder/executive director, Kristin Loomis, with helping to maintain interest in this group of herpesviruses.